Stay updated on Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated to include the posting of results for adverse events assessed during a 24-hour period following the copper Cu 64 PSMA I&T injection, with specific reporting dates and a new study document provided, while previous submissions and updates have been removed.SummaryDifference5%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
Stay in the know with updates to Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.